The in vivo assays performed during our study provided further verification indicating that exosomal miR-183-5p suppresses the tumorigenic ability of CRC cells and tumor angiogenesis via the inhibition of FOXO1 expression, which was evidenced by a reduction in tumor volume and weight along with decreased serum VEGFA level and MVD. The gene discussed is VEGFA; the disease is colorectal carcinoma.